Betahistine DiHCl(CAS: 5579-84-0)

Betahistine dihydrochloride (Betahistine DiHCl, CAS: 5579-84-0) is a compound used in the treatment of vertigo and Meniere's disease. It is a structural analog of histamine with selective agonist activity at H1 receptors, particularly in the vestibular system. Its molecular formula is C15H22Cl2N2O2. It is a white to off-white crystalline powder with poor solubility in water but soluble in acidic solutions.

Betahistine dihydrochloride (CAS: 5579-84-0) is primarily used in the treatment of vertigo and Meniere's disease. It is also used in the prevention of motion sickness and in research as a pharmacological tool to study histamine receptor function and signaling pathways in the central nervous system.

Betahistine dihydrochloride (CAS: 5579-84-0) is generally considered safe when used as directed for the treatment of vertigo and Meniere's disease. However, it may cause side effects such as palpitations, nausea, and headache. Patients should follow the prescription and avoid driving or operating machinery if they experience dizziness. Proper storage and handling should also be followed to minimize potential risks.

Betahistine dihydrochloride (CAS: 5579-84-0) should be stored in a tightly closed container to protect it from light. It should be kept in a cool, dry place, preferably at room temperature (15-30°C) and away from excessive heat and humidity. Avoid exposure to direct sunlight and store it in a place that is not accessible to children and pets.